Research Article
Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?
Table 2
Laboratory results according to the presence of high liver stiffness measurement (LSM > 7 kPa).
| | All patients | LSM ≤ 7 kPa | LSM > 7 kPa | | | () | () | () |
| AST (U/L)† | 28.2 ± 13.6 | 27.1 ± 10.6 | 37.6 ± 26.7 | 0.002 | ALT (U/L)† | 41.2 ± 23.0 | 39.3 ± 19.6 | 56.4 ± 39.3 | 0.003 | Fasting glucose (mg/dL)† | 108.4 ± 38.3 | 103.8 ± 29.7 | 146.0 ± 69.8 | <0.0001 | Triglyceride (mg/dL)† | 126.1 ± 67.8 | 125.5 ± 68.7 | 131.3 ± 61.5 | 0.712 | TC (mg/dL)† | 202.8 ± 42.9 | 203.6 ± 42.0 | 194.0 ± 49.9 | 0.431 | LDL-C (mg/dL)† | 126.1 ± 35.3 | 126.4 ± 34.3 | 123.4 ± 44.0 | 0.781 | HDL-C (mg/dL)† | 50.5 ± 13.2 | 51.1 ± 13.1 | 45.4 ± 13.0 | 0.095 | HOMA-IR† | 3.8 ± 6.1 | 3.1 ± 3.4 | 9.9 ± 14.8 | <0.0001 | LSM (kPa)† | 5.3 ± 2.9 | 4.5 ± 1.2 | 11.5 ± 4.7 | <0.0001 | Fatty liver by US‡ | 105 (63.6%) | 89 (60.5%) | 16 (88.9%) | 0.019 |
|
|
LSM: liver stiffness measurement; AST: aspartate aminotransferase; ALT: alanine aminotransferase; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; HOMA-IR: homeostatic model assessment insulin resistance; US: ultrasonography; †mean ± SD; ‡ (%).
|